Dextrin sulfate as a vaginal microbicide: Randomized, double-blind, placebo-controlled trial including healthy female volunteers and their male partners

Journal of Acquired Immune Deficiency Syndromes

Volumn 31, Issue 4, 2002, Pages 391-398

  Low Beer, Naomi ^a   Gabe, Rhian ^b   McCormack, Sheena ^b   Kitchen, Valerie S ^a   Lacey, Charles J ^a   Nunn, Andrew J ^b  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b Med Res Cncl Clinical Trials Unit   (United Kingdom)

Author keywords

Dextrin sulfate; Female controlled methods; HIV; Microbicide; Prevention; Virucide

Indexed keywords

DEXTRIN;

ADULT; ARTICLE; BREAKTHROUGH BLEEDING; CLINICAL TRIAL; COLPOSCOPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG INDUCED DISEASE; DRUG SAFETY; ERYTHEMA; FEMALE; FOLLOW UP; GEL; HUMAN; HUMAN EXPERIMENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTERVIEW; MALE; NORMAL HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEXUAL BEHAVIOR; SEXUAL INTERCOURSE; SEXUALITY; THROMBOCYTOPENIA; UNITED KINGDOM;

EID: 0036892030     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/00126334-200212010-00004     Document Type: Article

References (23)

1. UNAIDS. Report on the Global HIV/AIDS Epidemic. Geneva, Switzerland: UNAIDS, December 2001.
2. Kreiss J, Ngugi E, Holmes K, et al. Efficacy of nonoxynol 9 contraceptive sponge use in preventing heterosexual acquisition of HIV in Nairobi prostitutes. JAMA 1992;268:477-82.
3. Niruthisard S, Roddy RE, Chutivongse S. The effects of frequent nonoxynol-9 use on the vaginal and cervical mucosa. Sex Transm Dis 1991;18:176-9.
4. Roddy RE, Cordero M, Cordero C, et al. A dosing study of non-oxynol-9 and genital irritation. Int J STD AIDS 1993;4:165-70.
5. Poindexter AN, Levine H, Sangi-Haghpeykar H, et al. Comparison of spermicides on vulvar, vaginal, and cervical mucosa. Contraception 1996;53:147-53.
6. Stafford MK, Ward H, Flanagan A, et al. Safety study of non-oxynol-9 as a vaginal microbicide: Evidence of adverse effects. J Acquir Immune Defic Syndr Hum Retrovirol 1998;17:327-31.
7. Rosenstein IJ, Stafford MK, Kitchen VS, et al. Effect on normal vaginal flora of three intravaginal microbicidal agents potentially active against human immunodeficiency virus type 1. J Infect Dis 1998;177:1386-90.
8. Zekeng L, Feldblum PJ, Oliver RM, et al. Barrier contraceptive use and HIV infection among high-risk women in Cameroon. AIDS 1993;7:725-31.
9. Hira SK, Feldblum PJ, Kamanga J, et al. Condom and nonoxynol-9 use and the incidence of HIV infection in serodiscordant couples in Zambia. Int J STD AIDS 1997;8:243-50.
10. Roddy RE, Zekeng L, Ryan KA, et al. A controlled trial of non-oxynol 9 film to reduce male-to-female transmission of sexually transmitted diseases. N Engl J Med 1998;339:504-10.
11. Van Damme L, Ramjee G, Alary M. Effectiveness of COL-1492, a nonoxynol-9 vaginal gel, on HIV-1 transmission in female sex workers: A randomised controlled trial. Lancet 2002;360:971-7.
12. Shaunak S, Gooderham NJ, Edwards RJ, et al. Infection by HIV-1 blocked by binding of dextrin 2-sulphate to the cell surface of activated human peripheral blood mononuclear cells and cultured T-cells. Br J Pharmacol 1994;113:151-8.
13. McClure MO, Moore JP, Blanc DF, et al. Investigations into the mechanism by which sulfated polysaccharides inhibit HIV infection in vitro. AIDS Res Hum Retroviruses 1992;8:19-26.
14. Javan CM, Gooderham NJ, Edwards RJ, et al. Anti-HIV type 1 activity of sulfated derivatives of dextrin against primary viral isolates of HIV type 1 in lymphocytes and monocyte-derived macrophages. AIDS Res Hum Retroviruses 1997;13:875-80.
15. Weber J, Nunn A, O'Connor T, et al. "Chemical condoms" for the prevention of HIV infection: Evaluation of novel agents against SHIV(89.6PD) in vitro and in vivo. AIDS 2001;15:1563-8.
16. Shaunak S, Thornton M, John S, et al. Reduction of the viral load of HIV-1 after the intraperitoneal administration of dextrin 2-sulphate in patients with AIDS. AIDS 1998;12:399-409.
17. Stafford MK, Cain D, Rosenstein I, et al. A placebo-controlled, double-blind prospective study in healthy female volunteers of dextrin sulphate gel: A novel potential intravaginal virucide. J Acquir Immune Defic Syndr Hum Retrovirol 1997;14:213-8.
18. Chapman A. Assessment of Safety and Tolerance of Intravaginal Dextrin Sulphate Gel in Healthy Volunteers. ML Laboratories PLC report MLfiD070-01, February 2000.
19. Mauck CK, Baker JM, Birnkrant DB, et al. The use of colposcopy in assessing vaginal irritation in research. AIDS 2000;14:2221-7.
20. van De Wijgert J, Fullem A, Kelly C, et al. Phase 1 trial of the topical microbicide BufferGel: Safety results from four international sites. J Acquir Immune Defic Syndr 2001;26:21-7.
21. Elias CJ, Coggins C, Alvarez F, et al. Colposcopic evaluation of a vaginal gel formulation of iota-carrageenan. Contraception 1997; 56:387-9.
22. Van Damme L, Wright A, Depraetere K, et al. A phase I study of a novel potential intravaginal microbicide, PRO 2000, in healthy sexually inactive women. Sex Transm Infect 2000;76:126-30
23. Royce RA, Sena A, Cates W Jr, et al. Sexual transmission of HIV. N Engl J Med 1997;336:1072-8.